The content is available as a PDF (284.7 KB).
References
- 1.Meena J, Yadav J, Saini L, Yadav A, Kumar J. Clinical features and outcome of SARS-CoV-2 infection in children: A systematic review and meta-analysis. Indian Pediatr. 2020; S097475591600203 [E-pub ahead of print]. [DOI] [PMC free article] [PubMed]
- 2.Multisystem Inflammatory Syndrome (MIS-C). Information for Healthcare Providers about Multisystem Inflammatory Syndrome in Children. Case Report Form. 2020;2-4. Available from: https://emergency.cdc.gov/han/2020/han00432.asp. Accessed July 6, 2020.
- 3.Royal College of Paediatrics and Child Health Guidance: Paediatric Multisystem Inflammatory Syndrome Temporally Associated with COVID- 19. Available from: https://www.rcpch.ac.uk/sites/default/files/2020-05/COVID-19-Paediatric-multisystem-%20inflammatory%20syndrome-20200501.pdf. Accessed July 6, 2020.
- 4.World Health Organization. Multisystem inflammatory syndrome in children and adolescents with COVID-19: Scientific brief, 15 May 2020. Available from: https://apps.who.int/iris/handle/10665/332095. Accessed July 6, 2020.
- 5.European Centre for Disease Prevention and Control Country Experts. Rapid Risk Assessment: Paediatric inflammatory multisystem syndrome and SARS-CoV-2 infection in children. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-risk-assessment. Accessed July 6, 2020.
- 6.Feldstein LR, Rose EB, Horwitz SM, et al. Multisystem inflammatory syndrome in US children and adolescents. N Engl J Med. 2020;10.1056/NEJMoa2021680 [published online ahead of print].
- 8.Balasubramanian S, Nagendran TM, Ramachandran B, Ramanan AV. Hyper-inflammatory syndrome in a child with covid-19 treated successfully with intravenous immunoglobulin and tocilizumab. Indian Pediatr. 2020;S097475591600180 [E-pub ahead of print]. [DOI] [PMC free article] [PubMed]